EyePoint, Inc. Payments of Stock Issuance Costs
EyePoint, Inc. (EYPT) reported Payments of Stock Issuance Costs of $389.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-05
- EyePoint, Inc. payments of stock issuance costs for the quarter ending 2026-06-30 was $92.00K.
- EyePoint, Inc. payments of stock issuance costs for the quarter ending 2026-03-31 was $297.00K, a 2.06% increase year-over-year.
- EyePoint, Inc. payments of stock issuance costs for the quarter ending 2025-12-31 was $252.00K, a 30.96% decline year-over-year.
- EyePoint, Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00.
- EyePoint, Inc. payments of stock issuance costs for fiscal 2025 was $543.00K, a 19.20% decline from fiscal 2024.
- EyePoint, Inc. payments of stock issuance costs for fiscal 2024 was $672.00K, a 49.00% increase from fiscal 2023.
- EyePoint, Inc. payments of stock issuance costs for fiscal 2023 was $451.00K.
| Period end | Payments of Stock Issuance Costs 1 month | Payments of Stock Issuance Costs 1 month as first filed | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $389.00K 10-Q · filed 2026-08-05 | $641.00K derived: sum of 3 quarters · filed 2026-08-05 | $641.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $297.00K 10-Q · filed 2026-05-07 | $549.00K derived: sum of 2 quarters · filed 2026-05-07 | $549.00K derived: sum of 3 quarters · filed 2026-05-07 | $549.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $252.00K derived: sum of 2 quarters · filed 2026-03-05 | $252.00K derived: sum of 3 quarters · filed 2026-08-05 | $543.00K 10-K · filed 2026-03-05 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $291.00K 10-Q · filed 2025-11-06 | $656.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $291.00K 10-Q · filed 2026-08-05 | $656.00K derived: sum of 3 quarters · filed 2026-08-05 | $656.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $291.00K 10-Q · filed 2026-05-07 | $656.00K derived: sum of 2 quarters · filed 2026-05-07 | $656.00K derived: sum of 3 quarters · filed 2026-05-07 | $874.00K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $365.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $365.00K derived: sum of 2 quarters · filed 2026-03-05 | $583.00K derived: sum of 3 quarters · filed 2026-03-05 | $672.00K 10-K · filed 2026-03-05 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $218.00K derived: sum of 2 quarters · filed 2025-11-06 | $307.00K 10-Q · filed 2025-11-06 | $343.00K derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | $218.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $307.00K 10-Q · filed 2025-08-07 | $343.00K derived: sum of 3 quarters · filed 2025-08-07 | $758.00K derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $89.00K 10-Q · filed 2025-05-08 | $125.00K derived: sum of 2 quarters · filed 2025-05-08 | $540.00K derived: sum of 3 quarters · filed 2025-05-08 | $540.00K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $451.00K derived: sum of 2 quarters · filed 2025-03-06 | $451.00K derived: sum of 3 quarters · filed 2025-03-06 | $451.00K 10-K · filed 2025-03-06 | ||
| 2023-09-30 | $415.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $415.00K derived: sum of 2 quarters · filed 2024-11-07 | $415.00K 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | |||||
| 2016-01-31 | $1.30M 10-K · filed 2017-09-13 | |||||
| 2014-03-31 | $191.00K 10-K · filed 2016-09-13 | $186.00K 10-Q · filed 2014-05-14 | ||||
| 2013-09-30 | $39.00K 10-Q · filed 2013-11-13 | |||||
| 2013-07-31 | $890.00K 10-K · filed 2016-09-13 | |||||
| 2012-09-30 | $67.00K 10-Q · filed 2013-11-13 | |||||
| 2012-08-31 | $700.00K 10-K · filed 2015-09-10 | |||||
| 2011-03-31 | $37.00K 10-Q · filed 2012-05-10 | |||||
| 2011-01-31 | $1.00M 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |